Home › Novartis' Japan Unit Violates Protocol During Tasigna Drug Trial
 

Keywords :   


Novartis' Japan Unit Violates Protocol During Tasigna Drug Trial

2014-01-18 20:08:43| Biotech - Topix.net

Research and development of Novartis AG 's cancer drug Tasigna hit a roadblock when employees of the company's Japanese subsidiary transferred results from the research institutes where the trial was conducted to the University of Tokyo Hospital, where the results were being analyzed, violating the study's protocol, The Wall Street Journal reported ... (more)

Tags: japan unit trial drug

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.07Atlantic Tropical Weather Outlook
05.07Eastern North Pacific Tropical Weather Outlook
04.07Hurricane Beryl Graphics
04.07Hurricane Beryl Forecast Discussion Number 25
04.07Hurricane Beryl Public Advisory Number 25
04.07Summary for Hurricane Beryl (AT2/AL022024)
04.07Hurricane Beryl Wind Speed Probabilities Number 25
04.07Hurricane Beryl Forecast Advisory Number 25
More »